Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes

Applied and Environmental Microbiology

Volumn 79, Issue 23, 2013, Pages 7390-7397

  Knudsen, Gitte M ^a   Ng, Yin ^a   Gram, Lone ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC TREATMENT; BACTERIAL SPECIES; FERMENTABLE CARBOHYDRATE; LISTERIA MONOCYTOGENES; NITROFURANTOIN; PARENTAL STRAINS; STATIONARY PHASE;

ANTIBIOTICS; BACTERICIDES;

LISTERIA;

ANTIBIOTICS; BACTERIUM; CARBOHYDRATE; FERMENTATION; GROWTH RATE; MORTALITY; PESTICIDE; PHYSIOLOGY; SUBPOPULATION; SURVIVAL;

ANTIINFECTIVE AGENT; NITROFURANTOIN; NORFLOXACIN; SIGB PROTEIN, LISTERIA MONOCYTOGENES; SIGMA FACTOR;

ARTICLE; BACTERIAL COUNT; CARBOHYDRATE METABOLISM; DRUG EFFECT; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; LISTERIA MONOCYTOGENES; METABOLISM; MICROBIAL VIABILITY;

ANTI-BACTERIAL AGENTS; CARBOHYDRATE METABOLISM; COLONY COUNT, MICROBIAL; GENE DELETION; LISTERIA MONOCYTOGENES; MICROBIAL VIABILITY; NITROFURANTOIN; NORFLOXACIN; SIGMA FACTOR;

EID: 84888222895     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02184-13     Document Type: Article

References (60)

1. Rogers GB, Carroll MP, Bruce KD. 2012. Enhancing the utility of existing antibiotics by targeting bacterial behaviour? Br. J. Pharmacol. 165: 845-857.
2. Fauvart M, De GV, Michiels J. 2011. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 60:699-709.
3. Lewis K. 2007. Persister cells, dormancy, and infectious disease. Nat. Rev. Microbiol. 5:48-56.
4. Bigger J. 1944. Treatment of Staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244:497-500.
5. Grant SS, Kaufmann BB, Chand NS, Haseley N, Hung DT. 2012. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc. Natl. Acad. Sci. U. S. A. 109:12147-12152.
6. LaFleur MD, Qi Q, Lewis K. 2010. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54:39-44.
7. Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768-775.
8. Spoering AL, Lewis K. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-6751.
9. Luidalepp H, Joers A, Kaldalu N, Tenson T. 2011. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J. Bacteriol. 193:3598-3605.
10. Zhang Y, Yew WW, Barer MR. 2012. Targeting persisters for tuberculosis control. Antimicrob. Agents Chemother. 56:2223-2230.
11. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192:6191-6199.
12. Kint CI, Verstraeten N, Fauvart M, Michiels J. 2012. New-found fundamentals of bacterial persistence. Trends Microbiol. 20:577-585.
13. Kussell E, Kishony R, Balaban NQ, Leibler S. 2005. Bacterial persistence: a model of survival in changing environments. Genetics 169:1807-1814.
14. Buerger S, Spoering A, Gavrish E, Leslin C, Ling L, Epstein SS. 2012. Microbial scout hypothesis, stochastic exit from dormancy, and the nature of slow growers. Appl. Environ. Microbiol. 78:3221-3228.
15. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
16. Epstein SS. 2009. Microbial awakenings. Nature 457:1083.
17. Klapper I, Gilbert P, Ayati BP, Dockery J, Stewart PS. 2007. Senescence can explain microbial persistence. Microbiology 153:3623-3630.
18. Singh R, Ray P, Das A, Sharma M. 2009. Role of persisters and smallcolony variants in antibiotic resistance of planktonic and biofilmassociated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 58: 1067-1073.
19. Dörr T, Vulic M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8:e1000317. doi: 10.1371/journal.pbio.1000317.
20. Vega NM, Allison KR, Khalil AS, Collins JJ. 2012. Signaling-mediated bacterial persister formation. Nat. Chem. Biol. 8:431-433.
21. Dörr T, Lewis K, Vulic M. 2009. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5:e1000760. doi:10.1371/journal.pgen.1000760.
22. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of Escherichia coli. BMC Microbiol. 6:53. doi:10.1186/1471-2180-6-53.
23. Gerdes K, Maisonneuve E. 2012. Bacterial persistence and toxinantitoxin loci. Annu. Rev. Microbiol. 66:103-123.
24. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, Shoresh N, Biham O, Balaban NQ. 2010. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc. Natl. Acad. Sci. U. S. A. 107:12541-12546.
25. Cossart P. 2011. Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes. Proc. Natl. Acad. Sci. U. S. A. 108:19484-19491.
26. Goulet V, King LA, Vaillant V, de Valk H. 2013. What is the incubation period for listeriosis? BMC Infect. Dis. 13:11. doi:10.1186/1471-2334-13-11.
27. CDC. 2011. Multistate outbreak of listeriosis associated with Jensen Farms cantaloupe-United States, August-September 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1357-1358.
28. Sauders BD, Wiedmann M, Desjardins M, Fenlon C, Davenport N, Hibbs JR, Morse DL. 2001. Recurrent Listeria monocytogenes infection: relapse or reinfection with a unique strain confirmed by molecular subtyping. Clin. Infect. Dis. 33:257-259.
29. McLauchlin J, Audurier A, Taylor AG. 1991. Treatment failure and recurrent human listeriosis. J. Antimicrob. Chemother. 27:851-857.
30. Espaze EP, Reynaud AE. 1988. Antibiotic susceptibilities of Listeria: in vitro studies. Infection 16(Suppl 2):S160-S164.
31. Hof H, Nichterlein T, Kretschmar M. 1997. Management of listeriosis. Clin. Microbiol. Rev. 10:345-357.
32. Morvan A, Moubareck C, Leclercq A, Herve-Bazin M, Bremont S, Lecuit M, Courvalin P, Le MA. 2010. Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France. Antimicrob. Agents Chemother. 54:2728-2731.
33. Hof H, Waldenmeier G. 1988. Therapy of experimental listeriosis-an evaluation of different antibiotics. Infection 16(Suppl 2):S171-S174.
34. Feld L, Knudsen GM, Gram L. 2012. Bactericidal antibiotics do not appear to cause oxidative stress in Listeria monocytogenes. Appl. Environ. Microbiol. 78:4353-4357.
35. Boisivon A, Guiomar C, Carbon C. 1990. In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin, and trimethoprimsulfamethoxazole alone or in combination against Listeria monocytogenes. Eur. J. Clin. Microbiol. Infect. Dis. 9:206-209.
36. Gordon RC, Wofford RE, Hsu T, Fechner LL. 1980. Ampicillingentamicin synergism against Listeria monocytogenes in vitro. Infection 8:221-222.
37. Winslow DL, Damme J, Dieckman E. 1983. Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin. Antimicrob. Agents Chemother. 23:555-558.
38. Larsen CN, Nørrung B, Sommer HM, Jakobsen M. 2002. In vitro and in vivo invasiveness of different pulsed-field gel electrophoresis types of Listeria monocytogenes. Appl. Environ. Microbiol. 68:5698-5703.
39. WulffG, Gram L, Ahrens P, Vogel BF. 2006. One group of genetically similar Listeria monocytogenes strains frequently dominates and persists in several fish slaughter-and smokehouses. Appl. Environ. Microbiol. 72:4313-4322.
40. Linnan MJ, Mascola L, Lou XD, Goulet V, May S, Salminen C, Hird DW, Yonekura L, Hayes P, Weaver R, Audurier A, Plikaytis BD, Fanning SL, Kleks A, Broome CV. 1988. Epidemic listeriosis associated with Mexican-style cheese. N. Engl. J. Med. 319:823-828.
41. Allison KR, Brynildsen MP, Collins JJ. 2011. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216-220.
42. Phan-Thanh L, Gormon T. 1997. A chemically defined minimal medium for the optimal culture of Listeria. Int. J. Food Microbiol. 35:91-95.
43. Yeh PJ, Hegreness MJ, Aiden AP, Kishony R. 2009. Drug interactions and the evolution of antibiotic resistance. Nat. Rev. Microbiol. 7:460-466.
44. Eagle H, Musselman AD. 1948. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J. Exp. Med. 88:99-131.
45. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
46. Balaban NQ, Gerdes K, Lewis K, McKinney JD. 2013. A problem of persistence: still more questions than answers? Nat. Rev. Microbiol. 11: 587-591.
47. Stewart PS, Franklin MJ. 2008. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6:199-210.
48. Kim JS, Heo P, Yang TJ, Lee KS, Cho DH, Kim BT, Suh JH, Lim HJ, Shin D, Kim SK, Kweon DH. 2011. Selective killing of bacterial persisters by a single chemical compound without affecting normal antibioticsensitive cells. Antimicrob. Agents Chemother. 55:5380-5383.
49. Murugasu-Oei B, Dick T. 2000. Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG. J. Antimicrob. Chemother. 46:917-919.
50. Tanouchi Y, Pai A, Buchler NE, You L. 2012. Programming stressinduced altruistic death in engineered bacteria. Mol. Syst. Biol. 8:626.
51. Goldstein K, Rosdahl VT. 1981. High concentration of ampicillin and the Eagle effect among gram-negative rods. Chemotherapy 27:313-317.
52. Glaser P, Frangeul L, Buchrieser C, Rusniok C, Amend A, Baquero F, Berche P, Bloecker H, Brandt P, Chakraborty T, Charbit A, Chetouani F, Couve E, de Daruvar A, Dehoux P, Domann E, Dominguez-Bernal G, Duchaud E, Durant L, Dussurget O, Entian KD, Fsihi H, Garcia-del Portillo F, Garrido P, Gautier L, Goebel W, Gomez-Lopez N, Hain T, Hauf J, Jackson D, Jones LM, Kaerst U, Kreft J, Kuhn M, Kunst F, Kurapkat G, Madueno E, Maitournam A, Vicente JM, Ng E, Nedjari H, Nordsiek G, Novella S, de Pablos B, Perez-Diaz JC, Purcell R, Remmel B, Rose M, Schlueter T, Simoes N, Tierrez A, Vazquez-Boland JA, Voss H, Wehland J, Cossart P. 2001. Comparative genomics of Listeria species. Science 294:849-852.
53. Kim JS, Heo P, Yang TJ, Lee KS, Jin YS, Kim SK, Shin D, Kweon DH. 2011. Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals. Biochem. Biophys. Res. Commun. 413:105-110.
54. Pandey DP, Gerdes K. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966-976.
55. Fu Z, Donegan NP, Memmi G, Cheung AL. 2007. Characterization of MazFSa, an endoribonuclease from Staphylococcus aureus. J. Bacteriol. 189:8871-8879.
56. Freitag NE, Port GC, Miner MD. 2009. Listeria monocytogenes: from saprophyte to intracellular pathogen. Nat. Rev. Microbiol. 7:623-628.
57. Carpentier B, Cerf O. 2011. Review: persistence of Listeria monocytogenes in food industry equipment and premises. Int. J. Food Microbiol. 145:1-8.
58. Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, Contag CH. 2004. Extracellular replication of Listeria monocytogenes in the murine gallbladder. Science 303:851-853.
59. Hardy J, Chu P, Contag CH. 2009. Foci of Listeria monocytogenes persist in the bone marrow. Dis. Model. Mech. 2:39-46.
60. Brøndsted L, Kallipolitis BH, Ingmer H, Knöchel S. 2003. kdpE and a putative RsbQ homologue contribute to growth of Listeria monocytogenes at high osmolarity and low temperature. FEMS Microbiol. Lett. 219:233-239.